A closer look at the technologies used by Vanguard Clinical
Vanguard Clinical
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.ebvtrial.comRevenue
$11.3 MillionIndustry
About Vanguard Clinical
Moderna is engaged in the development and evaluation of investigational vaccines, notably focusing on the Epstein-Barr Virus (EBV) vaccine through clinical trials. The Eclipse Trial assesses the safety and immune response of their mRNA-1189 vaccine aimed at preventing Infectious Mononucleosis (mono), primarily affecting adolescents and young adults aged 15 to 24. The trial involves around 272 participants, requires a duration of approximately 18 months, and does not necessitate insurance for enrollment. Participants benefit from compensation for their time while contributing to advancing vaccine research within diverse populations.Explore more
SIC Code 87,873NAICS Code 54,541Show moreCompare Similar Companies to Vanguard Clinical
Compare insights from companies similar to Vanguard Clinical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vanguard Clinical
$11.3M
11-50
Private
-
-
N/A
Vanguard Clinical Tech Stack
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vanguard Clinical
Sign Up For FreeTo access detailed company insights
Moderna is engaged in the development and evaluation of investigational vaccines, notably focusing on the Epstein-Barr Virus (EBV) vaccine through clinical trials. The Eclipse Trial assesses the safety and immune response of their mRNA-1189 vaccine aimed at preventing Infectious Mononucleosis (mono), primarily affecting adolescents and young adults... Read More